Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active in Rheumatoid Arthritis (ReAct) trial.

G.R. Burmester; X. Mariette; C. Montecucco; I. Monteagudo-Saez; M. Malaise; A.G. Tzioufas; J.W.J. Bijlsma; K. Unnebrink; S. Kary; H. Kupper

Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active in Rheumatoid Arthritis (ReAct) trial.

Translated title of the contribution: Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active in Rheumatoid Arthritis (ReAct) trial.

G.R. Burmester, X. Mariette, C. Montecucco, I. Monteagudo-Saez, M. Malaise, A.G. Tzioufas, J.W.J. Bijlsma, K. Unnebrink, S. Kary, H. Kupper

Rheumatology & Clinical Immunology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active in Rheumatoid Arthritis (ReAct) trial.
Original language	Undefined/Unknown
Pages (from-to)	732-739
Number of pages	8
Journal	Annals of the Rheumatic Diseases
Volume	66
Issue number	6
Publication status	Published - 2007

Cite this

Burmester, G. R., Mariette, X., Montecucco, C., Monteagudo-Saez, I., Malaise, M., Tzioufas, A. G., Bijlsma, J. W. J., Unnebrink, K., Kary, S., & Kupper, H. (2007). Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active in Rheumatoid Arthritis (ReAct) trial. Annals of the Rheumatic Diseases, 66(6), 732-739.

@article{9d9456143dda42ebb02ec5cece7971bb,

title = "Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active in Rheumatoid Arthritis (ReAct) trial.",

author = "G.R. Burmester and X. Mariette and C. Montecucco and I. Monteagudo-Saez and M. Malaise and A.G. Tzioufas and J.W.J. Bijlsma and K. Unnebrink and S. Kary and H. Kupper",

year = "2007",

language = "Undefined/Unknown",

volume = "66",

pages = "732--739",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier",

number = "6",

}

Burmester, GR, Mariette, X, Montecucco, C, Monteagudo-Saez, I, Malaise, M, Tzioufas, AG, Bijlsma, JWJ, Unnebrink, K, Kary, S & Kupper, H 2007, 'Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active in Rheumatoid Arthritis (ReAct) trial.', Annals of the Rheumatic Diseases, vol. 66, no. 6, pp. 732-739.

Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active in Rheumatoid Arthritis (ReAct) trial. / Burmester, G.R.; Mariette, X.; Montecucco, C. et al.
In: Annals of the Rheumatic Diseases, Vol. 66, No. 6, 2007, p. 732-739.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active in Rheumatoid Arthritis (ReAct) trial.

AU - Burmester, G.R.

AU - Mariette, X.

AU - Montecucco, C.

AU - Monteagudo-Saez, I.

AU - Malaise, M.

AU - Tzioufas, A.G.

AU - Bijlsma, J.W.J.

AU - Unnebrink, K.

AU - Kary, S.

AU - Kupper, H.

PY - 2007

Y1 - 2007

M3 - Article

SN - 0003-4967

VL - 66

SP - 732

EP - 739

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 6

ER -